| Paper |
Title |
Page |
| THPMN078 |
The CONFORM Project: Construction of a NonScaling FFAG and its Applications
|
2886 |
| |
- R. J. Barlow
UMAN, Manchester
- N. Bliss
STFC/DL, Daresbury, Warrington, Cheshire
- T. R. Edgecock
STFC/RAL, Chilton, Didcot, Oxon
- N. Marks, H. L. Owen, M. W. Poole
STFC/DL/ASTeC, Daresbury, Warrington, Cheshire
- K. J. Peach
JAI, Oxford
- J. K. Pozimski
Imperial College of Science and Technology, Department of Physics, London
|
|
| |
The CONFORM project, recently funded as part of the UK 'Basic Technology' initiative, will build a 20 MeV Non-Scaling FFAG (EMMA) at Daresbury. The experience gained will be used for the design of a proton machine (PAMELA) for medical research, and other applications for Non-Scaling FFAGs in different regimes will be explored. The successful development of this type of accelerator will provide many opportunities for increased exploitation, especially for hadron therapy for treatment of tumours, and the project provides a framework where machine builders will work with potential user communities to maximise the synergies and help this to happen successfully.
|
|
| THPMN076 |
PAMELA - A Model for an FFAG based Hadron Therapy Machine
|
2880 |
| |
- J. K. Pozimski
Imperial College of Science and Technology, Department of Physics, London
- R. J. Barlow
UMAN, Manchester
- J. Cobb, T. Yokoi
OXFORDphysics, Oxford, Oxon
- B. Cywinski
University of Leeds, Leeds
- T. R. Edgecock
STFC/RAL, Chilton, Didcot, Oxon
- A. Elliott
Beatson Institute for Cancer Research, Glasgow
- M. Folkard, B. Vojnovic
Gray Cancer Institute, Northwood, Middlesex
- I. S.K. Gardner
STFC/RAL/ISIS, Chilton, Didcot, Oxon
- B. Jones
University Hospital Birmingham, Edgbaston, Birmingham
- K. Kirkby, R. Webb
UOSIBS, Guildford
- G. McKenna
University of Oxford, Oxford
- K. J. Peach
JAI, Oxford
- M. W. Poole
STFC/DL/ASTeC, Daresbury, Warrington, Cheshire
|
|
| |
Approximately one third of the world?s 15000 accelerators are used for tumour therapy and other medical applications. Most of these are room temperature cyclotrons: a few are synchrotrons. Neither of these have ideal characteristics for a dedicated medical accelerator. The characteristics of FFAGs make them ideally suited to such applications, as the much smaller magnet size, greater compactness and variable energy offers considerable cost and operational benefits especially in a hospital setting. In the first stage the work on PAMELA will focus on the optimization of the FFAG design to deliver the specific machine parameters demanded by therapy applications. In this phase of the PAMELA project the effort will concentrate on the design of a semi-scaling type FFAGs to deliver a 450 MeV/u carbon ion beam, including detailed lattice and tracking studies. The second stage will use the existing expertise in the BASROC consortium to undertake a design of the magnets and RF system for PAMELA. An outline of the overall concept of PAMELA will be discussed and the actual status of the work will be presented.
|
|